OPTUS Pharmaceutical Co., Ltd. (KOSDAQ: 131030)

OPTUS Pharmaceutical Revenue

OPTUS Pharmaceutical had revenue of 19.31B KRW in the quarter ending September 30, 2024, with 5.54% growth. This brings the company's revenue in the last twelve months to 78.80B, up 17.44% year-over-year. In the year 2023, OPTUS Pharmaceutical had annual revenue of 72.43B with 23.47% growth.

• Revenue (ttm): 78.80B
• Revenue Growth: +17.44%
• P/S Ratio: 1.09
• Revenue / Employee: 495.62M
• Employees: 159
• Market Cap: 90.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	72.43B	13.77B	23.47%
Dec 31, 2022	58.66B	1.34B	2.34%
Dec 31, 2021	57.32B	-3.51B	-5.77%
Dec 31, 2020	60.83B	385.58M	0.64%
Dec 31, 2019	60.44B	10.82B	21.80%